Early brain cancer trial seeks to boost radiation power

This early-stage study is testing whether a drug called quisinostat can effectively reach brain tumor tissue when given alongside standard radiation therapy. It is for adults with a specific, aggressive type of brain cancer called IDH-wildtype glioblastoma, either newly diagnosed or having returned after prior treatment. The trial first checks if the drug gets into the tumor during surgery, and if it does, patients continue receiving it with their planned radiation.